Tuesday, May 12, 2026
26.5 C
Bengaluru

Generics Only

[wpfilebase tag=file id=90 tpl=download-button /]

Inside this Issue

1. GUEST EDITORIAL: Generics Only – Does the Patient Benefit? by K. Hariram
How much will patients benefit from a regulation that only allows Doctors to prescribe generics?

2. Dinesh Thakur Tackles the Branded v. Generics Debate by Dinesh Thakur
This article features excerpts of a series of blogs written by well-know healthcare entrepreneur, activist and commentator, Dinesh Thakur, on the recent branded v. generics debate.

3. Quality, Not Price, is the Key Issue When Prescribing Generic Drugs in India by Anup Soans
In the absence of a standard drug regulatory mechanism, Indian doctors rely on the reputation of companies who have demonstrated their commitment to quality over time.

Hot this week

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Topics

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...
spot_img

Related Articles

spot_imgspot_img